Sangamo Therapeutics Announces Participation at 2021 Wedbush PacGrow Healthcare Conference

Rhea-AI Summary

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) will participate in a fireside chat at the 2021 Wedbush PacGrow Healthcare Conference on August 11 at 2:55 PM Eastern Time. The virtual session will be webcast live, providing investors access to insights about the company's genomic medicines pipeline, which leverages zinc finger genome engineering technology. The presentation will be available for later viewing on Sangamo's website, ensuring that stakeholders can stay informed about its progress and strategies in the clinical-stage biopharmaceutical sector.

Positive

• Participation in a reputable conference may enhance visibility among investors.
• Opportunity to discuss the genomic medicines pipeline, potentially attracting investor interest.

Negative

• None.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in a fireside chat at the 2021 Wedbush PacGrow Healthcare Conference on Wednesday, August 11^th at 2:55pm Eastern Time.

The virtual session will be webcast live and may be accessed on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline. Using ground-breaking science, including our proprietary zinc finger genome engineering technology and manufacturing expertise, Sangamo aims to create new genomic medicines for patients suffering from diseases for which existing treatment options are inadequate or currently don’t exist. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210809005159/en/

FAQ

When is Sangamo Therapeutics presenting at the Wedbush PacGrow Healthcare Conference?

Sangamo Therapeutics will present on August 11, 2021, at 2:55 PM Eastern Time.

How can I access the Sangamo Therapeutics presentation?

The presentation can be accessed live via webcast on the Sangamo Therapeutics website in the Investors and Media section.

What is Sangamo Therapeutics focusing on in its genomic medicines?

Sangamo Therapeutics is developing genomic medicines using zinc finger genome engineering technology aimed at treating diseases with inadequate existing options.

Is the Sangamo Therapeutics presentation available after the event?

Yes, the presentation will be available for viewing on the Sangamo Therapeutics website after the event.